CASI Pharmaceuticals, Inc. (CASIF) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.59 | -1.2% |
| 2024 | $-2.56 | -26.7% |
| 2023 | $-2.02 | +32.9% |
| 2022 | $-3.01 | -11.9% |
| 2021 | $-2.69 | +38.4% |
| 2020 | $-4.37 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-2.59 | -1.2% |
| 2024 | $-2.56 | -26.7% |
| 2023 | $-2.02 | +32.9% |
| 2022 | $-3.01 | -11.9% |
| 2021 | $-2.69 | +38.4% |
| 2020 | $-4.37 | — |